Healthcare
SOHM, Inc.(SHMN)
Live Price
Offline$0.0013
-3.70% today
1Y Change
+50.00%
Window
Jun 20, 2025 → Jun 12, 2026
- Market Cap
- —
- Revenue Growth
- +24.2%
- EPS Growth
- +166.7%
- Dividend Yield
- 0.0%
Coverage: 248 bars · Jun 20, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
SOHM, Inc. (SHMN) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 50.0% across the available one-year price window (Jun 20, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +24.2%, EPS growth of +166.7%, a dividend yield of 0.0%. What stands out right now is revenue +24.2%, EPS +166.7%, free cash flow 0.0% with operating margin -42.8% and ROIC -7.8%. Valuation is more restrained than many high-expectation growth names at price/sales 1.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SHMN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+24.2% vs +7.6% peer median
Operating Margin
Below sector median
-42.8% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating story is still moving forward
Revenue is running at +24.2% and EPS at +166.7%, with operating margin around -42.8%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SHMN
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SHMN Max Drawdown
-63.16%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SHMN and SPY.
Company Overview
SOHM, Inc.
Other OTC
SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. It offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. The company also exports its products. SOHM, Inc. was founded in 2005 and is based in Corona, California.
- Leadership
- Baron Night
- IPO Date
- Mar 31, 2010
- Employees
- 145
- Street Address
- 4740 Green River Road
- Mailing
- Corona, CA, 92880
- Region
- Corona, CA, US
- Reporting Currency
- USD
- Investor Line
- 714-522-6700
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- —
- Price/Sales
- 1.6
- Price/Book
- 0.9
Growth
- Revenue
- +24.2%
- EPS
- +166.7%
- Free Cash Flow
- 0.0%
Profitability
- Gross Margin
- 74.5%
- Operating Margin
- -42.8%
- Net Margin
- -43.0%
- ROE
- -46.8%
- ROIC
- -7.8%
Balance Sheet
- Debt/Equity
- 0.68
- Current Ratio
- 1.08
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.